Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to unraveling the scientific nuances that drive pharmaceutical innovation. Piroxicam-Beta-Cyclodextrin (CAS 96684-39-8) exemplifies this dedication, offering a sophisticated approach to enhancing the therapeutic profile of piroxicam. This pharmaceutical intermediate is more than just a combination of molecules; it's a carefully engineered system designed to optimize drug delivery and patient response.
The core of Piroxicam-Beta-Cyclodextrin's advantage lies in the principle of cyclodextrin inclusion complexation. Beta-cyclodextrin, a cyclic oligosaccharide, possesses a unique toroidal structure with a hydrophilic exterior and a hydrophobic interior cavity. This structure allows it to encapsulate poorly soluble drug molecules like piroxicam, forming an inclusion complex. This process significantly increases the aqueous solubility of piroxicam, a critical factor for efficient absorption in the body. The piroxicam beta cyclodextrin pharmaceutical intermediate thus provides a soluble and stable form of the active pharmaceutical ingredient.
The improved solubility directly translates to enhanced bioavailability. When administered, the Piroxicam-Beta-Cyclodextrin complex dissolves more readily, allowing for faster absorption through the gastrointestinal tract. This accelerated absorption contributes to a quicker onset of action, which is particularly valuable for pain management where rapid relief is often desired. This aspect is crucial when considering NSAID complex for pain relief, as it addresses a key limitation of many traditional formulations.
Beyond faster absorption, the complexation can also influence the drug's release profile. The piroxicam is gradually released from the cyclodextrin cavity, potentially leading to a more sustained therapeutic effect and reduced peak concentrations, which might contribute to better tolerability. This scientific understanding underpins the piroxicam beta cyclodextrin benefits that NINGBO INNO PHARMCHEM CO.,LTD. brings to the market.
For researchers and formulators, Piroxicam-Beta-Cyclodextrin (CAS 96684-39-8) represents a valuable tool to explore innovative drug delivery systems. By choosing to buy this high-quality intermediate, companies can integrate these scientific advancements into their product pipelines, aiming for superior patient outcomes and a competitive edge in the pharmaceutical landscape.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
